AMGN vs EOLS · P/E 24, rev $36.75B vs rev $266.3M
Amgen Inc (AMGN) versus Evolus Inc (EOLS) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Evolus Inc (EOLS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported AMGN revenue for 2025-12-31 was $36.75B. Net income was $7.71B. Revenue was up 10.0% from 2024-12-31 to 2025-12-31. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported EOLS revenue for 2024-12-31 was $266.3M. Net income was -$50.4M. Revenue was up 31.8% from 2023-12-31 to 2024-12-31. EOLS currently screens at market cap $597.0M.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. EOLS currently screens at market cap $597.0M.
Not investment advice. Open the AMGN and EOLS stock pages for the full models.
Not investment advice.